Marshall Wace’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.47M | Buy |
+279,501
| New | +$4.47M | 0.01% | 1100 |
|
|
2024
Q4 | – | Sell |
-26,548
| Closed | -$447K | – | 2423 |
|
|
2024
Q3 | $447K | Sell |
26,548
-955,500
| -97% | -$16.1M | ﹤0.01% | 1814 |
|
|
2024
Q2 | $11.7M | Sell |
982,048
-253,095
| -20% | -$3.02M | 0.02% | 601 |
|
|
2024
Q1 | $13.7M | Buy |
1,235,143
+336,286
| +37% | +$3.73M | 0.02% | 562 |
|
|
2023
Q4 | $7.78M | Buy |
898,857
+401,454
| +81% | +$3.48M | 0.01% | 636 |
|
|
2023
Q3 | $3.81M | Buy |
497,403
+458,889
| +1,191% | +$3.51M | 0.01% | 859 |
|
|
2023
Q2 | $277K | Buy |
+38,514
| New | +$277K | ﹤0.01% | 1742 |
|